{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:59:38Z","timestamp":1761893978026},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.mehy.2004.03.042","type":"journal-article","created":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T12:31:36Z","timestamp":1088166696000},"page":"1057-1064","source":"Crossref","is-referenced-by-count":30,"title":["Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia"],"prefix":"10.1016","volume":"63","author":[{"given":"J.W.","family":"Downing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ramasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.H.","family":"Minzter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Paschall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W.","family":"Sundell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.03.042_BIB1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1054\/ijoa.2002.0944","article-title":"Editorial: maternal mortality and anaesthesia in Africa: a South African perspective","volume":"11","author":"Rout","year":"2002","journal-title":"Int. J. Obstet. Anesth"},{"key":"10.1016\/j.mehy.2004.03.042_BIB2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0146-0005(00)80050-6","article-title":"Preeclampsia: what we know and what we do not know","volume":"24","author":"Roberts","year":"2000","journal-title":"Semin. Perinatol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJM200008103430601","article-title":"Neurologic and developmental disability after extremely preterm birth","volume":"343","author":"Wood","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.mehy.2004.03.042_BIB4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1056\/NEJMp020166","article-title":"Magnesium sulfate for preeclampsia","volume":"348","author":"Greene","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.mehy.2004.03.042_BIB5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.285.5.633","article-title":"Prospects for research in reproductive health and birth outcomes","volume":"285","author":"Goldenberg","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2004.03.042_BIB6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/plac.2001.0676","article-title":"Uterine artery doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses","volume":"22","author":"Aardema","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2004.03.042_BIB7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0140-6736(93)90889-O","article-title":"Pre-eclampsia: more than pregnancy-induced hypertension","volume":"341","author":"Roberts","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.042_BIB8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0306-9877(87)90180-0","article-title":"Control of human placental blood flow","volume":"23","author":"Howard","year":"1987","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.042_BIB9","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1172\/JCI105693","article-title":"Uneven distribution of maternal and fetal placental blood flow, as demonstrated using macroaggregates, and its response to hypoxia","volume":"46","author":"Power","year":"1967","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.mehy.2004.03.042_BIB10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0143-4004(95)90011-X","article-title":"Effects of variation in oxygen tension on responses of the human fetoplacental vasculature to vasoactive agents in vitro","volume":"16","author":"Read","year":"1995","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2004.03.042_BIB11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.0960-7692.2001.602.doc.x","article-title":"Editorial \u2013 the dynamic placenta: a closer look at the pathophysiology of placental hemodynamics in uteroplacental compromise","volume":"18","author":"Sebire","year":"2001","journal-title":"Ultrasound Obstet. Gynecol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1054\/mehy.2001.1538","article-title":"The role of intraplacental vascular smooth muscle in the dynamic placenta: a conceptual framework for understanding uteroplacental disease","volume":"58","author":"Sebire","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.042_BIB13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0002-9378(92)91863-6","article-title":"Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal\u2013placental circulation","volume":"166","author":"Myatt","year":"1992","journal-title":"Am. J. Obstet. Gynecol"},{"issue":"Suppl","key":"10.1016\/j.mehy.2004.03.042_BIB14","first-page":"A107","article-title":"Sodium nitroprusside (SNP) obtunds the vasopressor action of 5-hydroxytryptamine (5-HT) on the placental intravillous circulation","volume":"92","author":"Downing","year":"2000","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2004.03.042_BIB15","first-page":"P, 90","article-title":"Sodium nitroprusside (SNP) inhibits hypoxic feto-placental vasoconstriction (HFPV) in the dual perfused, single isolated human placental cotyledon","volume":"96","author":"Downing","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB16","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1097\/00000542-200104001-00050","article-title":"Phosphodiesterase (PDE5) receptor inhibition moderates the vasopressor effect of 5-hydroxytryptamine (5-HT) on the fetoplacental vasculature","volume":"94","author":"Downing","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB17","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1097\/00000542-200104001-00051","article-title":"Phosphodiesterase (PDE5) placental receptor inhibition obtunds hypoxic fetoplacental vasoconstriction (HFPV) in the human placenta","volume":"94","author":"Downing","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0076-6879(96)69016-8","article-title":"Nitric oxide\u2013cyclic GMP signal transduction system","volume":"269","author":"Hobbs","year":"1996","journal-title":"Methods Enzymol"},{"issue":"Suppl","key":"10.1016\/j.mehy.2004.03.042_BIB19","first-page":"A11","article-title":"Intracellular receptors for cGMP and cAMP in human placenta","volume":"92","author":"Francis","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","article-title":"Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase","volume":"216","author":"Loughney","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.mehy.2004.03.042_BIB21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(02)08528-8","article-title":"Nitric oxide, phosphodiesterase inhibition, and adaption to hypoxic conditions","volume":"359","author":"Wilkins","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.042_BIB22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-0528.1985.tb01044.x","article-title":"Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance","volume":"92","author":"Trudinger","year":"1985","journal-title":"Br. J. Obstet. Gynaecol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1054\/mehy.2001.1347","article-title":"`Cor placentale': placental intervillus\/intravillus blood flow mismatch is the pathophysiological mechanism in severe intrauterine growth restriction due to uteroplacental disease","volume":"57","author":"Sebire","year":"2001","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.042_BIB24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0020-7292(00)00314-3","article-title":"Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, preeclampsia and eclampsia","volume":"72","author":"Shaamash","year":"2001","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.mehy.2004.03.042_BIB25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/cs0930051","article-title":"Reduction of placental nitric oxide synthase activity in preeclampsia","volume":"93","author":"Brennecke","year":"1997","journal-title":"Clin. Sci"},{"key":"10.1016\/j.mehy.2004.03.042_BIB26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.RES.88.1.12","article-title":"Interactions between nitric oxide and lipid oxidation pathways \u2013 implications for vascular disease","volume":"88","author":"O'Donnell","year":"2001","journal-title":"Circ. Res"},{"key":"10.1016\/j.mehy.2004.03.042_BIB27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of preeclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.042_BIB28","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1161\/01.RES.86.9.e85","article-title":"Vascular superoxide production by NAD (P)H oxidase \u2013 association with endothelial dysfunction and clinical risk factors","volume":"86","author":"Guzik","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.mehy.2004.03.042_BIB29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0076-6879(96)69044-2","article-title":"Nitric oxide as antiinflammatory agent","volume":"269","author":"Granger","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB30","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMe020054","article-title":"Editorial: hypertension, angiotensin II, and oxidative stress","volume":"346","author":"Sowers","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.mehy.2004.03.042_BIB31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1016254","article-title":"Oxidative stress and altered endothelial cell function in preeclampsia","volume":"16","author":"Davidge","year":"1998","journal-title":"Semin. Reprod. Endocrinol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am. J. Obstet. Gynecol"},{"issue":"2","key":"10.1016\/j.mehy.2004.03.042_BIB33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000492","article-title":"Antiplatelet agents for preventing and treating pre-eclampsia","author":"Knight","year":"2000","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.mehy.2004.03.042_BIB34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomized trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.042_BIB35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2044.1977.tb10004.x","article-title":"Laryngeal oedema associated with pre-eclamptic toxaemia","volume":"32","author":"Brock-Utne","year":"1977","journal-title":"Anaesthesia"},{"key":"10.1016\/j.mehy.2004.03.042_BIB36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00008480-200206000-00002","article-title":"Recent advances in pulmonary vascular disease","volume":"14","author":"Adatia","year":"2002","journal-title":"Curr. Opin. Pediatr"},{"key":"10.1016\/j.mehy.2004.03.042_BIB37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0029-7844(95)80024-7","article-title":"Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia","volume":"86","author":"Grunewald","year":"1995","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0146-0005(99)80055-X","article-title":"Animal models of preeclampsia","volume":"23","author":"Podjarny","year":"1999","journal-title":"Semin. Perinatol"},{"key":"10.1016\/j.mehy.2004.03.042_BIB40","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/00000542-200012000-00017","article-title":"Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia","volume":"93","author":"Sakawi","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2004.03.042_BIB41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mob.2002.121102","article-title":"Stress in pregnancy: a new Wistar rat model for human preeclampsia","volume":"186","author":"Takiuti","year":"2002","journal-title":"Am. J. Obstet. Gynecol"},{"issue":"9A","key":"10.1016\/j.mehy.2004.03.042_BIB42","doi-asserted-by":"crossref","first-page":"19M","DOI":"10.1016\/S0002-9149(03)00828-2","article-title":"Efficacy and tolerability of tadalafil, a novel phosphodiesterase inhibitor, in treatment of erectile dysfunction","volume":"92","author":"Padma-Nathan","year":"2003","journal-title":"Am. J. Cardiol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T16:21:58Z","timestamp":1549470118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0306987704003007"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.03.042","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}